Dr Reddys Laboratories (RDY) Net Equity Issued and Repurchased (2009 - 2026)
Dr Reddys Laboratories' Net Equity Issued and Repurchased was $711,426 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 32.6% from $1.05 million a year earlier and down 72.8% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Dr Reddys Laboratories' Net Equity Issued and Repurchased was $6.68 million through Sep 30, 2026, up 27.9% year-over-year; for FY2026 (ended Mar 31, 2026), it was $4.5 million.
- In earlier fiscal years, Net Equity Issued and Repurchased was -$14.43 million in FY2025, $10 million in FY2024 (+100.0%), $5 million in FY2023 (+25.0%) and $4 million in FY2022.
- The fiscal Q2 2027 figure marks the lowest quarterly Net Equity Issued and Repurchased since fiscal Q1 2025.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in two of the last four quarters, with growth averaging 212.8%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was fiscal Q1 2026 (growth of 905.5%); the worst was fiscal Q3 2024 (a decline of 89.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | - |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 711,425.74 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 711,425.74 |
| Jun 30, 2026 | 2.62 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 227,766.49 |
| Mar 31, 2024 | 373,288.03 |
| Dec 31, 2023 | 108,089.07 |
| Sep 30, 2023 | 8.30 Mn |
| Jun 30, 2023 | 961,561.37 |
| Mar 31, 2023 | 121,648.52 |
| Dec 31, 2022 | 986,574.04 |
| Sep 30, 2022 | 438,996.75 |
| Jun 30, 2022 | 402,021.49 |
| Mar 31, 2022 | 106,392.59 |
| Dec 31, 2021 | 600,596.85 |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | 1.99 Mn |
| Mar 31, 2021 | -18.69 Mn |
| Dec 31, 2020 | 974,844.50 |
API Access
Dr Reddys Laboratories Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();